Text and Data Mining valid from 2019-02-01
First Online: 4 February 2019
Compliance with Ethical Standards
: Harsh K. Patel declares that he has no conflict of interest.Alok A. Khorana has received compensation from Bayer, Sanofi, Parexel, Halozyme Therapeutics, Pfizer, Seattle Genetics, Pharmacyclics, PharmaCyte Biotech, AngioDynamics, LEO Pharma, TriSalus, and Medscape/WebMD for service as a consultant; has received travel support from Bayer, Sanofi, Parexel, Janssen, Halozyme Therapeutics, Pfizer, Seattle Genetics, AngioDynamics, LEO Pharma, and Medscape/WebMD; and is the Co-Chair of the CASSINI Steering Committee, as well as the National Coordinator for the MARINER trial, both of which are funded by Janssen.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines)